The Russian Corona vaccine Sputnik for use in India will be 850 million doses per year

New Delhi, dated 13 April 2021, Tuesday

The Sputnik vaccine is expected to arrive in the Indian market soon amid the Corona crisis. The government approved the vaccine yesterday. As a result, a third corona vaccine will also be available in India.

Meanwhile, the Russian Direct Investment Fund has announced that 850 million doses of the Sputnik vaccine will be produced in India every year. The vaccine has undergone the necessary clinical trials in Russia and is in its third phase in India, with positive results. In India, he will work with Dr. Reddy on vaccines.

According to the Russian Fund, Sputnik has been approved for use in three of the world's most populous countries, making India the 60th country to approve. Russia claims that the vaccine is 91 percent effective. The decision to allow the vaccine is a milestone. Because it will develop a comprehensive cooperation between the two countries. The vaccine provides complete protection against corona.